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Abstract
Background: Acute pancreatitis rarely complicates pregnancy. Although most pregnant women
with acute pancreatitis have associated gallstones, less common causes such as drugs have been
reported.
Case presentation: We report the case of a 34-year-old woman who underwent medical
abortion with mifepristone and gemeprost and received codeine as pain-relief during the induction
of abortion. She developed a severe acute necrotizing pancreatitis which required 14 days of
intensive care. Other possible etiological factors, i.e. gallstone, alcohol intake and hyperlipidemia,
were excluded.
Conclusions: The reported case of acute pancreatitis was most likely drug-induced.
Background
Acute pancreatitis rarely complicates pregnancy. Acute
pancreatitis complicated 1 in 3300 pregnancies at a large
public hospital in Dallas, Texas [1], whereas in southern
California 1 in 1500 women were affected [2]. Other pub-
lished reports cite incidences ranging widely from 1 in
1000 to 1 in 12,000 live births [3,4]. Although most preg-
nant women with acute pancreatitis have associated gall-
stones, less common causes such as trauma, drugs, and
ethanol ingestion have also been reported [5,6]. We report
the case of a woman who developed severe acute necrotiz-
ing pancreatitis that required 14 days of intensive care fol-
lowing medical abortion.
Case presentation
The patient was a pregnant gravida IV, para I, 34-year-old
woman who due to severe malformation of the fetus
underwent medical abortion. She was healthy, was not on
any medication and had no known allergies. There was no
history of alcohol or any other substance abuse. Previous
interrupted pregnancies had been due to miscarriages in
the first trimester and on one occasion medical abortion
due to a diagnosed Turner's syndrome of the fetus.
A chorion villi sample during the present pregnancy had
shown a normal female chromosomal constitution. How-
ever, repeated ultrasound examinations revealed poor
fetal growth and a complete lack of amniotic fluid. There
was no sign of fluid leakage. Ultrasound examination at
week 17 showed a cystic formation in the fetal abdomen,
most likely representing a serious renal malformation not
compatible with life. The patient decided to terminate
pregnancy and was admitted to Uppsala University Hos-
pital for a medical abortion. Treatment was initiated at
week 18 of pregnancy with 600 mg mifepristone given
orally after which the patient experienced mild gastric
pain, which is commonly seen after mifepristone admin-
istration [7].
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The next day, four vaginal pessaries of 1 mg gemeprost
were administered every third hour. At the same time as
treatment with gemeprost was initiated, she also received
oral doses of a codeine 30 mg/paracetamol 500 mg com-
bination due to her above mentioned mild gastric pain.
Abortion was induced the same day and the patient
underwent exceresis. The fetus exhibited skeletal malfor-
mations. However, six hours after administration of the
first doses of gemeprost and of codeine/paracetamol, the
patient developed severe epigastric pain. She had at this
point received a total of 2 mg of gemeprost, 60 mg of
codeine, and 1 g of paracetamol, apart from the 600 mg of
mifepristone given the day before. Her pain was at first
judged as gastritis, but omeprazole had little effect. Visual
analogue scale (VAS) score was at this stage between 8 and
9 out of 10, where 10 indicates maximum subjective pain.
Repeated doses of 2 mg morphine i.v., and at one occa-
sion 5 mg ketobemidon i.m., were necessary to relieve the
pain. An acute CT of the abdomen revealed a swollen pan-
creas as seen with pancreatitis, and plasma amylase levels
were elevated (up to 23 µkat/L, reference interval 0.2–0.8
µkat/L). Although a CT scan is not optimal for imaging
gallstones, there were no signs of cholelithiasis or dilated
biliary ducts. The patient's pancreatitis was classified as
severe acute necrotizing pancreatitis, a condition with a
high mortality rate [8,9]. When the diagnosis was made,
she was immediately transferred to the intensive care unit.
Her pain was later controlled through epidural anaesthet-
ics. Results from repeated blood samples are shown in
table 1. The patient was febrile and had an increased leu-
kocyte blood count and plasma CRP as well as decreased
levels of antithrombin and elevated levels of fibrinogen
and fibrin d-dimer, indicating activation of the coagula-
tion system. Apart from a decreased plasma albumin level,
all liver parameters were normal. The values slowly
returned towards normal during the following 14 days of
intensive care. During this time, antibiotic treatment with
cefuroxime and metronidazole was given. At follow up 1
month later, her plasma amylase level had not yet
returned to normal (2.0 µkat/L) and was still elevated
after 2 months (1.1 µkat/L).
Examination of the fetus revealed a likely Potter's syn-
drome with malformations of the hands and feet, poor
development of the skeleton in the lower extremities, 13
ribs and a fused lumbar vertebrae. The kidneys were
absent, there was a cloacal malformation, and only two
vessels were seen in the umbilical cord.
Table 1: Blood monitoring during the 14 days of hospitalization.
Day 1 
(day)
Day 1 
(evening)
Day 2 Day 3 Day 4 
(morning)
Day 4 
(evening)
Day 5 Day 6 Day 8 Day 10 Day 14
B-leukocyte count (109/L) 21.0 16.3 18.7 19.5 17.0 17.6 14.9 13.6 - 12.3 7.4
B-hemoglobin (g/L) 115 100 86 81 80 84 82 112 115 110 125
B-platelet count (109/L) 269 217 208 200 226 216 249 - - 373 -
P-CRP (mg/L) 126 147 199 329 290 210 190 173 122 75 <5
P-sodium (mmol/L) 137 - - - - - - 136 140 141 -
P-potassium (mmol/L) 3.4 - - - - - - 3.6 4.0 4.3 -
P-creatinine (µm o l / L ) 8 0 6 4 6 27 8 6 6 6 2 6 77 57 4 8 1 -
P-glucose (mmol/L) - - - - - 8.3 - - - - -
P-urea (mmol/L) - 1.6 1.8 2.1 - - 1.4 - - - -
P-cytatin C (mg/L) - - - 0.80 - - - - - - -
GFR. calculated (ml/min) - - - 100 - - - - - - -
P-bilirubin (µmol/L) 11 12 10 5 8 - - - - - -
P-albumin (g/L) - 26 21 22 22 - - - 29 28 -
P-triglycerides. fasting (mmol/L) - - - - - - - - - 2.33 -
P-calcium (mmol/L) - - - - 1.75 - - - - - -
P-LD (µkat/L) 6.5 4.7 4.3 5.5 5.7 - - - - - -
P-ALP (µkat/L) 2.8 2.1 2.1 3.1 3.5 - - - - - -
P-amylase (µkat/L) 23 16 11 4.1 2.4 - 2.3 3.0 - - -
P-ASAT (µkat/L) 0.46 0.32 0.37 0.30 0.26 - - - - - -
P-ALAT (µkat/L) - - 0.12 0.25 0.11 - - - - - -
INR - 1.2 1.2 1.2 1.1 1.1 1.1 - 1.0 - -
P-antithrombin (%) - 75 64 - 65 - 30 - - - -
P-APT time (s) - 28 28 30 31 29 - - - - -
P-fibrinogen (g/L) - 3.7 3.7 - 4.2 - - - - - -
P-fibrin d-dimer (mg/L) - 0.5 0.5 - 0.8 - - - - - -BMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/1
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Drug-induced pancreatitis is considered to be rare [10].
However, the exclusion of other possible etiological fac-
tors combined with the coincidence in time with the
intake of both codeine/paracetamol and mifepristone and
gemeprost make these drugs suspect as causative agents.
On her previous medical abortion she received only two
vaginal pessaries of 1 mg gemeprost, and no mifeprisone,
without complications. On this occasion, she also
received a combination of codeine 30 mg/paracetamol
500 mg. These facts would point out mifepristone or pos-
sibly gemeprost as the likely causative agents. However,
there have been a handful of published cases of pancrea-
titis complicating treatment with codeine [10-12]. A com-
mon feature of these reported cases are previous
cholecystectomies [11,12]. The patient reported here had
not been cholecystectomized. Also, three cases of possible
codeine-precipitated pancreatitis have been reported since
1965 to the Swedish Drug Information System (SWEDIS)
handling reports on suspected adverse reactions to drugs
used in Sweden [13]. Codeine is known to cause rapid but
transient spasm of the sphincter of Oddi [11]. Laboratory
studies have shown that codeine may cause a mild, tran-
sient hyperamylasemia [11]. Pancreatitis following para-
cetamol overdose have been previously reported [11], but
the doses taken in the present case are unlikely to have
been causative. Gemeprost is a synthetic prostaglandin E1
(PGE1) analogue. Studies indicate that PGE1 is a modula-
tor of pancreatic blood flow and protein production. For
instance, PGE1 stimulated the production and secretion
of alpha-amylase from minces of porcine pancreas in vitro
[14], and enzyme output in dogs in vivo [15]. PGE1 further
increases mesenteric and pancreatic blood flow [15].
Thus, PGE1 is not devoid of actions on the pancreas. Pro-
gesterone has also been shown to exert modulating action
on the pancreas. In rats, progesterone stimulated pancre-
atic cell proliferation in vivo [16]. Progesterone receptors
have also been shown to be present in human pancreatic
tissue [17]. However, the effect of a progesterone receptor
antagonist such as mifepristone on the pancreas has not
been studied. Evidence thus exists that both PGE1 and
progesterone exert modulatory action on the pancreas,
but to our knowledge, no reports on pancreatitis follow-
ing treatment with gemeprost or mifepristone have been
published.
It is worth noting that a small number of pregnant women
with acute pancreatitis have an associated hyperlipidemia,
usually hypertriglyceridemia. In the reported case, the p-
triglyceride level 10 days after diagnosis was elevated to
2.33 mmol/L (about 75 mg/dl). However, mild to moder-
ate hyperlipidemia may be secondary to acute pancreatitis
[18], and it is generally believed that a triglyceride level of
>1,000 mg/dl is needed to precipitate an episode of acute
pancreatitis [19]. Furthermore, a follow-up measurement
of p-triglycerides six months later was 1.22 mmol/L.
Conclusions
In conclusion, due to the coincidence in time and exclu-
sion of other possible etiological factors such as cholelith-
iasis, alcohol and hyperlipidemia, the reported case of
severe acute necrotizing pancreatitis was most likely drug-
induced. Since codeine, although uncommonly, has pre-
viously been reported to precipitate pancreatitis, this drug
must be the first to suspect. However, we cannot exclude
gemeprost or mifepristone as the causative agents.
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